Storys zum Thema Medizin, Gesundheit

x-cardiac GmbH

x-cardiac and Hemedic Partner to Bring AI-Based Medical Devices to ICUs Across Scandinavia

Berlin/Copenhagen (ots) - x-cardiac GmbH, a leading provider of AI-based health solutions and a spin-off of the German Heart Center of Charité and Charité - Universitätsmedizin Berlin, announced today a strategic distribution partnership with the Danish company Hemedic ApS to expand the reach of its AI-based medical devices in Scandinavia. Through this partnership, ...

Astrasana Holding AG

Astrasana Group receives Swissmedic license for the cultivation of medical cannabis

Zurich (ots) - The Astrasana Group is pleased to announce that its subsidiary, Astrasana Pharma AG, has been granted the official cultivation license for medical cannabis by Swissmedic. This authorization permits the controlled cultivation of cannabis plants with a THC content above 1% and marks an important milestone in the expansion of the Group's pharmaceutical ...

FDI World Dental Federation

Join FDI World Dental Federation's 2025 Virtual Summit to Advance Sustainable Practices in Dentistry and Reduce the Profession's Environmental Impact

Grünenthal Group

Maren Thurow starts as new Head Global Communications at Grünenthal

Aachen (ots) - Maren Thurow has today assumed the role of Vice President and Head Global Communications at Grünenthal. She succeeds Florian Dieckmann, who has played a key role in evolving the company’s Communications department since 2021. In her new position, Maren will oversee Grünenthal’s communications operations across all markets and lead the team based at ...

Globegarden Gmbh

globegarden once again named one of Switzerland's Best Workplaces(TM) in 2025

Zürich (ots) - On 15th of May, 2025, globegarden was named one of the "Best Workplaces(TM) in Switzerland" by Great Place To Work®. This recognition places the leading childcare network among Switzerland's top employers, known for its inclusive, appreciative, and development-focused workplace culture. The award is based on an anonymous survey of over 1,000 employees ...

NeutroFlow

NeutroFlow: Leading European Medical Consortium Awarded €2.5 Million Grant from EIC Transition Programme to Advance Predictive Biomarker Development for Immunotherapy Response

Heidelberg, Germany, Milan, Seville, Spain and Binyamina, Israel (ots/PRNewswire) - A European-led consortium comprising Heidelberg University Hospital (UKHD), the European Institute of Oncology (IEO), Virgen Macarena University Hospital, and OncoHost today announced that it has been awarded a €2.5 million grant ...

Johnson & Johnson MedTech

Personalized Treatment Plans Influence European Public's Willingness to Share Health Data

Leeds, England (ots/PRNewswire) - A global survey reveals Europe's growing confidence in the use of data and technology to transform healthcare and surgery. A global survey from Johnson & Johnson MedTech, a global leader in cardiovascular, orthopaedic, surgery and vision solutions, reveals that Europeans are favorable to sharing their health data in exchange for ...

Healthcare Holding Schweiz AG

Healthcare Holding Switzerland Acquires Aestheticbedarf

Baar, Switzerland (ots/PRNewswire) - Healthcare Holding Schweiz AG, a leading provider of services and distributor of medical technology in Switzerland, has expanded its portfolio with the acquisition of Aestheticbedarf AG. Healthcare Holding Schweiz is managed by Winterberg Advisory GmbH. Healthcare Holding Schweiz AG has successfully closed the acquisition of Aestheticbedarf AG, headquartered in Affoltern, an ...

Healthcare Holding Schweiz AG

Healthcare Holding Switzerland Acquires CDP Swiss

Baar, Switzerland (ots/PRNewswire) - Healthcare Holding Schweiz AG, a leading provider of services and distributor of medical technology in Switzerland, has expanded its portfolio by acquiring CDP Swiss AG and CDP Austria GmbH. Healthcare Holding Schweiz is managed by Winterberg Advisory GmbH. Healthcare Holding Schweiz AG has successfully closed the acquisition of CDP Swiss AG, based in Affoltern, and its subsidiary, CDP ...

Acousia Therapeutics GmbH

Acousia Therapeutics Reaches 50% Patient Enrollment Milestone in Phase 2 PROHEAR Study

Tübingen, Germany (ots) - Acousia Therapeutics GmbH announced that it has successfully enrolled 50% of patients in its ongoing Phase 2 clinical trial, the PROHEAR Study, evaluating ACOU085 (INN: bimokalner) for the prevention of cisplatin-induced hearing loss in patients with testicular cancer undergoing chemotherapy. Cisplatin is a cornerstone in modern oncology and ...

Scantox A/S

Annual Report 2024 released by Scantox Group

Ejby, Denmark (ots/PRNewswire) - Scantox Group has released their 2024 Annual Report today. It highlights the many activities the company has done over the year to shape the future of a business that in so many ways contribute to improve lives worldwide through the development of new drugs and treatments. "Our 2024 result shows high profitable growth from transformational acquisitions. We are very pleased with these ...

Immunity Pharma

Immunity Pharma Presents New Data Supporting the Efficacy of IPL344 in ALS

Jerusalem (ots/PRNewswire) - - Results from phase 2a trial in ALS patients were published in Muscle and Nerve. - Statistically significant 58% to 64% slower ALSFRS-R progression rate in IPL344-treated patients compared to the matched PRO-ACT records. - NfL was reduced by 27% for patients treated for at least two months. - Unadjusted median survival for participants in ...

Isomorphic Labs

Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic programs into the clinic

London (ots/PRNewswire) - Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline. Isomorphic Labs, an AI-first drug design and development company, today announced it has raised $600 ...

Isomorphic Labs

Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic programs into the clinic

London (ots/PRNewswire) - Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline. Isomorphic Labs, an AI-first drug design and development company, today announced it has raised $600 ...

FDI World Dental Federation

1

1

A Happy Mouth Is a Happy Mind: FDI World Dental Federation features new song to raise awareness of the link between oral health and mental well-being

Oclean

Oclean: Women vs. Men - Oral Hygiene Research Report

Warsaw, Poland (ots/PRNewswire) - Taking care of a healthy and beautiful smile is a key part of daily routine, but approaches to oral hygiene differ depending on gender. Research conducted by the independent research and analysis firm IQS, commissioned by the Oclean brand, shows that women visit the dentist more often and are more consistent in brushing their teeth. Men, on the other hand, tend to focus on functionality ...

Briya

Briya Expands Access to European Real-World Data Through Strategic Partnership with Casa Sollievo della Sofferenza

San Giovanni Rotondo, Italy (ots/PRNewswire) - Briya, a leading healthcare data retrieval network, is proud to announce a strategic partnership with Casa Sollievo della Sofferenza, one of Italy's premier hospitals renowned for its advanced medical care and research initiatives. This collaboration marks a significant ...

Schweizerischer Nationalfonds / Fonds national suisse

Double knock-out for malaria

TOOsonix A/S

TOOsonix Partners with MikronMed to Introduce Innovative Dermatological Therapy in the Nordic Region

Copenhagen, Denmark (ots/PRNewswire) - A groundbreaking dermatological alliance will bring innovative dermatological treatment to the 27 million residents of the Nordic Region, offering rapid and efficient treatment for the most common skin cancer and various skin conditions - often completed in under 90 seconds. ...

Grünenthal Group

Apotex licenses exclusive Canadian rights to Qutenza® from Grünenthal

Aachen, Germany & Toronto, Canada, (ots) - Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, announced today that they have entered into a strategic licensing agreement whereby Apotex will have the exclusive Canadian rights to Qutenza®, a topical, non-systemic, ...

Isotopia; Kinectrics

Kinectrics and Isotopia Enter Agreement for Supply of Gadolinium-160 (Gd-160) to Support Production of Terbium-161 (Tb-161) for Advanced Radiotherapeutics

Toronto (ots/PRNewswire) - Kinectrics and Isotopia have announced a groundbreaking agreement under which Kinectrics will provide Isotopia with a reliable supply of Gadolinium-160 (Gd-160). This critical isotope will enable Isotopia's production of Terbium-161 (Tb-161), a medical isotope showing great promise and ...

Lyfegen; EVERSANA

Lyfegen and EVERSANA Collaborate to Revolutionize Drug Pricing and Access with AI-Driven Insights

Basel, Switzerland (ots/PRNewswire) - Lyfegen, a global innovator in drug market access, pricing, and rebate management, has announced a transformative collaboration with EVERSANA®, a leading provider of global commercial services to the life sciences industry, to revolutionize drug pricing and access through artificial intelligence-driven insights. By combining data ...

Norgine

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commercialisation in Europe.

London (ots/PRNewswire) - Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the treatment of WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis), a rare ...

Titian Software; Labguru

Keith Hale appointed as Group CEO to Unite Titian Software & Labguru (BioData)

London (ots/PRNewswire) - Keith Hale has been appointed as Group CEO of Titian Software and Labguru (BioData Inc.), two leading providers of laboratory data management solutions, as part of the goal to accelerate the future of digital lab operations. A well-known fintech executive, Keith brings 33 years of growth-focused software and technology leadership. He ...